Stock Updates: Cyclo Therapeutics, Lucy Scientific, Pasithea Therapeutics and Apple Making Waves
- June 05th, 2023
- 372 views
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) has entered into a binding agreement with Rafael Holdings, Inc. (NYSE: RFL).
Under the agreement, Rafael will acquire 4,000,000 shares of CYTH's common stock, along with warrants to purchase an additional 4,000,000 shares, for a total purchase price of $5,000,000.
$CYTH is currently trading at $1.42, reflecting a slight increase of $0.01 (+0.71%).
In other news, Lucy Scientific Discovery Inc. (Nasdaq: LSDI) has made a proposal to acquire Pasithea Therapeutics Corp. (Nasdaq: KTTA) through a cash-and-stock transaction.
The proposal suggests a per-share acquisition price of $0.85, comprising $0.60 in cash and $0.25 in Lucy stock.
Trading for both $LSDI and $KTTA has been halted in light of this development.
Additionally, BofA Securities has raised the price target for Apple Inc. (Nasdaq: AAPL) from $176 to $190, while Evercore ISI Group increased it from $190 to $210.
Currently, $AAPL is trading at $183.58, reflecting a positive movement of $2.63 (+1.45%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login